Among tumor-infiltrating CD45+ leukocytes, the percentage and the absolute number of CD8+/tissue-resident conventional DCs (cDC1s) were significantly increased in KV-treated mice when compared to KK-treated and control mice (Figure 1C). This evidence concerns the gene CD8A and neoplasm.